stella
beta
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC) — Stella
Home
/
NSCLC (Non-small Cell Lung Cancer)
/
View on ClinicalTrials.gov
Recruiting
Back to NSCLC (Non-small Cell Lung Cancer) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Tangdu Hospital, Xi’an, Shanxi